Vicarious Surgical, Inc. · OTC:RBOT
Vicarious Surgical — Investor Presentation (November 2023)
22 slides from Vicarious Surgical's investor presentation, Nov 13, 2023
Slide 1: Investor Presentation November 2023
INVESTOR PRESENTATION NOVEMBER 2023
Slide 2: Disclaimer
0 0 | SUMMA R Y VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 2 DISCLAIMER This presentation includes “forward - looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. The company’s actual results may dif
Slide 3: Key Investment Highlights
0 0 | SUMMA R Y VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 3 KEY INVESTMENT HIGHLIGHTS 1 VICARIOUS SURGICAL ESTIMATES FROM DATA SOURCED FROM LSI MARKET SIZE ANALYSIS 2022 DATA AND PUBLIC FILINGS. ASSUMES $3,319 REVENUE PER PROCEDURE CURRENTLY REALIZED BY LEGACY ROBOTIC COMPANY. 2 PARTNER
Slide 4: Surgery Today
SURGERY TODAY 1 VICARIOUS SURGICAL ESTIMATES FROM DATA SOURCED FROM LSI MARKET SIZE ANALYSIS 2022 DATA AND PUBLIC FILINGS. ASSUMES $3,319 REVENUE PER PROCEDURE CURRENTLY REALIZED BY LEGACY ROBOTIC COMPANY. 2 VICARIOUS SURGICAL ESTIMATES FROM LSI MARKET DATA. 2022 DATA 3 DHARAP SB, BARBANIYA P, NAVGA
Slide 5: The Vicarious Surgical System
VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 5 T H E VICARIOU S SURGICA L S Y S TEM 01
Slide 6: The System
VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 6 0 1 | TH E VI C ARIOU S SURGI C A L S Y S TEM THE SYSTEM 1 VICARIOUS SURGICAL SYSTEM IS CAPABLE OF TROCAR SIZES AS LOW AS 1.2CM. CURRENT DISPOSABLES REQUIRE 1.8CM TROCAR. 2 INCLUDES ADDITIONAL FEATURES EXPECTED AFTER INITIAL LAUNCH AND NECESSA
Slide 7: Unwanted Force Build-Up
1 UN W ANTED FORCE BUILD - UP 1x 50x 20x 2 3 4 5 6 7 8 9 40x 30x 10x EXISTING SURGICAL ROBOTS IF THEY H A D 5 + DEGREE S OF FREED O M I N TH E B O D Y DECOUPLED ACTUATORS: OUR ENABLING TECHNOLOGY PROPRIETARY TECHNOLOGY: • ISOLATES CABLE PATHWAYS • REMOVES BUILD UP OF FORCE BETWEEN JOINTS CABLE BREAK
Slide 8: One Small Incision
ONE SMALL INCISION 0.5 - 1.5cm INCISIONAL COMPLICATION R A T E 20% 10% 1.8cm INCISION SIZE MINIMIZING PATIENT COMPLICATIONS THROUGH 1.8CM TROCAR 1 • <2.0CM INCISION ABILITY TO UTILIZE OBTURATOR • >2.0CM INCISION REQUIRES SCALPEL • OBTURATOR DRIVES COMPLICATION RATES DOWN BY SEPARATING MUSCLE FIBERS
Slide 9: Unrestricted Surgeon Workspace
UNRESTRICTED SURGEON WORKSPACE NEARLY 360 ƒ WORKSPACE IN THE ABDOMEN THROUGH ONE 1.8CM 1 TROCAR THE 13 DEGREES OF FREEDOM POWERED BY PROPRIETARY DECOUPLED MOTION PROVIDES SURGEONS UNPRECEDENTED DEXTERITY AND RANGE OF MOTION LEGACY SYSTEMS HAVE LIMITED WORKING AREA COLLISIONS INSIDE AND OUTSIDE THE P
Slide 10: Sensing and Visualization
SENSING AND VISUALIZATION COLLECTING HIGH QUALITY DATA: THE KEY TO ENABLE SURGEON DECISION SUPPORT, MACHINE LEARNING, AND BROADER AI CAPABILITY 1 0 1 | TH E VI C ARIOU S SURGI C A L S Y S TEM 10 MEASUREMENT OF FORCE AND POSITION WITH SENSORS FROM WITHIN ABDOMINAL CAVITY DECOUPLED ACTUATORS ENABLE UN
Slide 11: Attractive Cost Model
11 0 1 | TH E VI C ARIOU S SURGI C A L S Y S TEM ATTRACTIVE COST MODEL • Capital equipment is primarily non - robotic as movement is ge n e r a t ed f r om within t h e a b do m en • Cost of goods of capital equipment is expected to be significantly l o w er than c om p e ting p r oduct s 1 • Decoup
Slide 12: Future of Surgery
VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 12 FUTUR E OF SURGERY 02
Slide 13: Transforming Robotics to Become the Standard of Care
TRANSFORMING ROBOTICS TO BECOME THE STANDARD OF CARE 1 DHARAP SB, BARBANIYA P, NAVGALE S. INCIDENCE AND RISK FACTORS OF POSTOPERATIVE COMPLICATIONS IN GENERAL SURGERY PATIENTS. CUREUS. 2022 NOV 1;14(11):E30975. DOI: 10.7759/CUREUS.30975. PMID: 36465229; PMCID: PMC9714582. 2 INCLUDES ADDITIONAL FEATU
Slide 14: Pioneering Automated Patient Protection
PIONEERING AUTOMATED PATIENT PROTECTION 1 TO GENERATE IMPROVED PATIENT OUTCOMES BUILDING TOWARDS PROCEDURAL AUTOMATION PROCEDU R AL AUTOMATION Our pl a t f orm is uniquely engi n ee r ed t o deli v er r eliabl e , r e p e a table re sults th r ough futu r e “ au t opil o t” au t om a tion UNIQUE SYS
Slide 15: Pathway to Commercialization
VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 15 P A TH W A Y T O COMMERCIALIZATION 03
Slide 16: Hospital System Partners
HOSPITAL SYSTEM PARTNERS KEY PARTNERSHIPS WITH FOUR LEADING HEALTHCARE PROVIDERS REPRESENTING OVER 250 HOSPITALS AND 200 SURGERY CENTERS CREATING THE FOUNDATION FOR A STRONG COMMERICAL LAUNCH CLINICAL EXECUTION Joint si t e selection a n d clinical trial sup p o r t f or F D A submi s sion PLATFORM
Slide 17: Indication Pathway and Initial Market Value
1 COLORECTAL, SMALL BOWEL, BARIATRIC, ESOPHAGEAL, BARIATRIC, STOMACH (NON - ENDOSCOPIC), LSI WW 2022 DATA 2 VICARIOUS SURGICAL ESTIMATES FROM LSI WW 2022 DATA, INCLUDES SOME PATIENTS WHO CHOSE TO NOT HAVE HERNIAS REPAIRED WITH LEGACY TECHNIQUES 3 LSI WW 2022 DATA 4 HYSTERECTOMY, OOPHORECTOMY, COLPOP
Slide 18: Our Roadmap
0 3 | P A TH W A Y T O COMMERCIALIZ A TION 18 20 2 3 NOTE: ACTUAL MILESTONES AND TIMELINE MAY VARY AS CERTAIN ACTIVITIES ARE BEYOND VICARIOUS SURGICAL’S CONTROL F D A De N o v o Submission Fi r s t Clinical Patient V e r sion 1 . 0 D e sign Lock H C A & UH C en t e r s o f E x c elle n c e Manu f ac
Slide 19: Team and Investors
T E A M A N D IN V E S T O R S 04 VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 19
Slide 20: Our Team and Investors
0 4 | OU R TEA M A N D IN V E S T ORS VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 20 EXPERIENCED MANAGEMENT TEAM CO - FOUNDER, CHIEF TECHNOLOGY OFFICER SAMMY KHALIFA CO - FOUNDER, CHIEF EXECUTIVE OFFICER ADAM SACHS CHIEF FINANCIAL OFFICER BILL KELLY CHIEF OPERATING OFFICER JOHN MAZZOLA VP
Slide 21: Experienced Board and Advisors
EXPERIENCED BOARD AND ADVISORS SEASONED IN V E S T OR S 1 Bill G a t e s EXECUTIVE CHAIRMAN DAVID STYKA BOARD DIRECTOR DAVID HO BOARD DIRECTOR SAMMY KHALIFA BOARD DIRECTOR ADAM SACHS BOARD DIRECTOR BEVERLY HUSS BOARD DIRECTOR DONALD TANG BOARD DIRECTOR RIC FULOP F or m er O p e r a tional L e ader a
Slide 22: Thank You
VICARIOUS SURGICAL INVESTOR PRESENTATION NOVEMBER 2023 T H AN K Y OU 78 F ou r th A v enue W altha m , MA, 024 5 1 vicariou s su r gical . c om +1.617.868.1700 VICARIOUS SURGICAL 22
Vicarious Surgical — Investor Presentation (November 2023) on 6ix